1. Home
  2. SAVA vs PBHC Comparison

SAVA vs PBHC Comparison

Compare SAVA & PBHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cassava Sciences Inc.

SAVA

Cassava Sciences Inc.

HOLD

Current Price

$2.29

Market Cap

103.9M

Sector

Health Care

ML Signal

HOLD

Logo Pathfinder Bancorp Inc. (MD)

PBHC

Pathfinder Bancorp Inc. (MD)

N/A

Current Price

$13.84

Market Cap

87.8M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
SAVA
PBHC
Founded
1998
1859
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
103.9M
87.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SAVA
PBHC
Price
$2.29
$13.84
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
863.6K
2.5K
Earning Date
03-02-2026
01-30-2026
Dividend Yield
N/A
2.83%
EPS Growth
N/A
N/A
EPS
N/A
1.07
Revenue
N/A
$44,154,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$13.17
Revenue Growth
N/A
24.40
52 Week Low
$1.15
$13.35
52 Week High
$4.98
$17.50

Technical Indicators

Market Signals
Indicator
SAVA
PBHC
Relative Strength Index (RSI) 48.84 43.26
Support Level $1.97 $14.03
Resistance Level $2.19 $14.35
Average True Range (ATR) 0.11 0.21
MACD 0.05 0.01
Stochastic Oscillator 85.14 47.44

Price Performance

Historical Comparison
SAVA
PBHC

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

About PBHC Pathfinder Bancorp Inc. (MD)

Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.

Share on Social Networks: